Valvular Heart Disease Associated With Fenfluramine Detected 7 Years After Discontinuation of Treatment

Annals of Thoracic Surgery

Volumn 83, Issue 4, 2007, Pages 1541-1543

  Greffe, Guillaume ^a   Chalabreysse, Lara ^a   Mouly Bertin, Carine ^a   Lantelme, Pierre ^b   Thivolet, Françoise ^a   Aulagner, Gilles ^a   Obadia, Jean François ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; FENFLURAMINE;

ADULT; ANAMNESIS; AORTA VALVE DISEASE; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HISTOLOGY; HUMAN; IATROGENIC DISEASE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

ADULT; AORTIC VALVE; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENFLURAMINE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; MITRAL VALVE; RISK ASSESSMENT; SEROTONIN AGENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33947322408     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.11.031     Document Type: Article

References (10)

1. Langreth R. Critics claim diet clinics misuse obesity drugs. Wall Street Journal (1997) B8 March 31
2. Jick H., Vasilakis C., Weinrauch L.A., Meier C.R., Jick S.S., and Derby L.E. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med 339 (1998) 719-724
3. Loke Y.K., Derry S., and Pritchard-Copley A. Appetite suppressants and valvular heart disease-a systematic review. BMC Clin Pharmacol 2 (2002) 6
4. Mast S.T., Jollis J.G., Ryan T., Anstrom K.J., and Crary J.L. The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. Ann Intern Med 134 (2001) 261-266
5. Prasad A., Mehra M., Park M., Scott R., Uber P.A., and McFadden P.M. Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg 71 (2001) 397
6. Caccitolo J.A., Connolly H.M., Rubenson D.S., Orszulak T.A., and Schaff H.V. Operation for anorexigen-associated valvular heart disease. JTCS 122 (2001) 656-664
7. Connolly H.M., Crary J.L., and McGoon M.D. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337 (1997) 581-588
8. Steffee C.H., Singh H.K., and Chitwood W.R. Histologic changes in three explanted native cardiac valves following use of fenfluramines. Cardiovasc Pathol 8 (1999) 245-253
9. Volmar K.E., and Hutchins G.M. Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents. Arch Pathol Lab Med 125 (2001) 1555-1561
10. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U. S. Department of Health and Human Services interim public health recommendations, November 1997. MMWR Morb Mortal Wkly Rep 46 (1997) 1061-1066